arrow_back Back to App

VA Medicinal Cannabis Research: Study on Chronic Pain and PTSD in Veterans

This Act mandates the Department of Veterans Affairs (VA) to conduct extensive research and clinical trials on the effects of cannabis on veterans suffering from chronic pain and Post-Traumatic Stress Disorder (PTSD). The goal is to scientifically determine how cannabis affects their health, including potential reduction in opioid use and improvement in quality of life. Participation is voluntary and does not affect veterans' eligibility for other benefits.
Key points
The VA must conduct an 18-month observational study on the health outcomes of cannabis use among veterans with chronic pain and PTSD, utilizing medical records and interviews.
If criteria are met, subsequent clinical trials will test various forms and ratios of THC/CBD, focusing on pain reduction, PTSD symptoms, and decreasing opioid and benzodiazepine dosages.
Participation in these studies does not jeopardize a veteran's eligibility for any existing VA health or financial benefits, protecting their rights and access to care.
article Official text account_balance Process page
VOTING RESULTS
2023-04-26
58%
For 57
Against 42
Abstain 0
Full voting results open_in_new
Failed
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_326
Sponsor: Sen. Tester, Jon [D-MT]
Process start date: 2023-02-09
Voting date: 2023-04-26
Voting no: 97
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

VA Medicinal Cannabis Research Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_326.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-02-09.

What are the main provisions?

Key points include:

  • The VA must conduct an 18-month observational study on the health outcomes of cannabis use among veterans with chronic pain and PTSD, utilizing medical records and interviews.
  • If criteria are met, subsequent clinical trials will test various forms and ratios of THC/CBD, focusing on pain reduction, PTSD symptoms, and decreasing opioid and benzodiazepine dosages.
  • Participation in these studies does not jeopardize a veteran's eligibility for any existing VA health or financial benefits, protecting their rights and access to care.
What is the specific legal status?

The current status is Failed.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Where is the official voting record?

The official roll call vote is recorded at: voting record

Who is the primary sponsor?

The primary sponsor is Sen. Tester, Jon [D-MT].

What is the latest detailed status?

The latest detailed status is: Motion by Senator Schumer to reconsider the vote by which cloture on the motion to proceed to S. 326 was not invoked (Record Vote No. 97) entered in Senate.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health Benefits